Cite
HARVARD Citation
Sadetsky, N. et al. (n.d.). 6OComprehensive genomic profiling and outcomes among metastatic melanoma patients (pts) treated with first-line cancer immunotherapy (CIT) in a real-world setting. Annals of oncology. p. . [Online].